|
|
Article: Medical food reduces medical costs and use of anti-convulsant medication.(Report)
- Article from:
- NewsRx Health & Science
- Article date:
- November 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented today at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress.
The results of the HealthCore, Inc. study, funded by Pamlab, L.L.C., which manufactures the medical food Metanx[R], showed that patients' health plan costs to treat diabetes-related peripheral neuropathy were reduced by about $400 a year.
"In this study, health care savings were driven by lower costs related to hospitalization and ...